NEW YORK (GenomeWeb) – PDI said after the close of the market Wednesday that its Interpace Diagnostics subsidiary will enter the molecular diagnostics market through the acquisition of two microRNA-based from Asuragen.
NEW YORK (GenomeWeb) – Molecular diagnostics developer DiamiR said today it has received a grant from the Michael J. Fox Foundation for Parkinson's Research for a study to validate the use of microRNA biomarkers for detecting Parkinson's early.
NEW YORK (GenomeWeb) – Trovagene has assigned all of its miRNA patents to London-based firm GenSignia IP and licensed back the technology, the San Diego-based company disclosed in its Form 10-Q filed with the US Securities and Exchange Commission recently.
NEW YORK (GenomeWeb News) – Blood expression levels of a dozen microRNAs may help in distinguishing individuals affected by Alzheimer's disease from those who aren't, according to a study appearing online today in Genome Biology.